Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clinical improvement in a patient with neuromyelitis optica following therapy with the anti-IL-6 receptor monoclonal antibody tocilizumab.
Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.
Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).
Intrathecal versus Oral Baclofen; a Matched Cohort Study of Spasticity, Pain, Sleep, Fatigue and Quality of Life.
Temperature dependence of water diffusion pools in brain white matter.
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
Goal attainment in cognitive rehabilitation in MS patients.
Treatment Adherence and Transitioning Youth in Pediatric Multiple Sclerosis.
Improving Multiple Sclerosis Plaque Detection Using a Semiautomated Assistive Approach.
[Immunomodulatory properties of stem mesenchymal cells in autoimmune diseases.]
Suppression of IL-10 production by calcitriol in patients with multiple sclerosis.
Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis.
Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.
Cecal Ligation and Puncture Results in Long-Term Central Nervous System Myeloid Inflammation.
NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review.
Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances.
Cerebrospinal fluid concentrations of ghrelin in patients with multiple sclerosis.
Multicenter measurements of myelin water fraction and geometric mean T2 : Intra- and intersite reproducibility.
Inducible Expression of a Truncated Form of Tau in Oligodendrocytes Elicits Gait Abnormalities and a Decrease in Myelin: Implications for Selective CNS Degenerative Diseases.
Glucosamine modulates T cell differentiation through downregulating N-linked glycosylation of CD25.
Structural Analysis of Phenothiazine Derivatives as Allosteric Inhibitors of the MALT1 Paracaspase.
T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2.
Chronic illness and return to work: a social cognitive perspective.
Pages
« first
‹ previous
…
377
378
379
380
381
382
383
384
385
…
next ›
last »